Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$31.83 – $37.03
94% from low
Exchange
ARCX
ETS
Borrow rate
12.45%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $295.8M | $361.5M | $437.3M | $427.6M | $449.4M | $527.7M | $642.4M | $667.5M |
| Cost of revenue | $120.1M | $112.8M | $146.1M | $159.2M | $151.0M | $144.8M | $167.8M | $167.8M |
| Gross profit | $175.7M | $248.8M | $291.1M | $268.4M | $298.3M | $382.9M | $474.6M | $499.7M |
| Gross margin | 59.4% | 68.8% | 66.6% | 62.8% | 66.4% | 72.6% | 73.9% | 74.9% |
| R&D | $21.2M | $23.1M | $22.3M | $29.1M | $27.4M | $28.6M | $33.7M | $33.5M |
| Operating income | $52.4M | $110.1M | $116.5M | $37.6M | $33.8M | $6.9M | $69.5M | $71.7M |
| EBITDA | $68.0M | $129.9M | $141.8M | $81.2M | $91.9M | $94.1M | $180.0M | $186.6M |
| Net income | $32.7M | $65.4M | $66.1M | $27.1M | $34.8M | −$39.2M | $7.8M | $22.6M |
| Net margin | 11.1% | 18.1% | 15.1% | 6.3% | 7.7% | -7.4% | 1.2% | 3.4% |
| EPS (diluted) | 17.64 | 6.36 | 5.40 | 2.16 | 2.88 | -3.24 | 0.63 | 1.80 |
Annual figures · source: Financial Modeling Prep
No company description on file.
No one on the platform currently holds INOV.
No tracked institution reports a position in INOV as of their last filing.
| Execution date | Ratio |
|---|---|
| 2004-04-23 | 1-for-500reverse |
No one on the platform has traded INOV yet.
| +0.23% |
| $10M |
| — |
| FSBDFidelity Sustainable Core Plus Bond ETF | $47.77 | -0.13% | $13M | — |
| MRGRProShares - Merger ETF | $45.45 | +0.14% | $14M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$INOV Data-driven healthcare play. Strong platform, growing patient analytics. Watching closely for potential entry point. strong article: https://beyondspx.com/article/inovalon-inov-transforming-healthcare-with-data-driven-insights
View on StockTwits ↗$INOV This one is going be tough for the shorts to control. These numbers are just too good. This is one of the best launches I've seen in 30+ years of trading small bios. This works, and the future is only going to get better. My advise to any shorts here is to cover soon. Big Pharma is not going to let this go. There is going to be a bidding war for this one. It could come fast.
View on StockTwits ↗$XBI $CRMD $AUPH $INOV $FBIO See, these are the people we are dealing with.
View on StockTwits ↗$BMY $AUPH $CRMD $INOV $TGTX Bristol Myers Squibb (BMY) announces a public offering of senior unsecured notes totaling $13 billion to fund acquisitions and general corporate purposes.
View on StockTwits ↗$INOV Last week I posted about the trend-line I was following since the breakout in mid-October. Been away for the Holiday and just happened to look at it again and happy to report that we seem to be well past that point. This is going much higher before the decision on the PDUFA date. With all the positive stuff I'm seeing around, I would not be surprised if BP does not scoop this up prior to the approval. GLTA
View on StockTwits ↗$INOV With this volume, MM need shares to sell. So they sell first, gather them later. They are gathering them now.
View on StockTwits ↗@steeq hell no I went to $INOV for a 3. 00+
View on StockTwits ↗Watch👀👀 high volume $LYLTQ $FLG $CNTB $INM $INOV
View on StockTwits ↗$INOV - Calls open interest is downshifting for Inovalon Holdings this week https://www.macroaxis.com/stock-options/INOV/Inovalon-Holdings?utm_source=dlvr.it&utm_medium=stocktwits
View on StockTwits ↗$INOV - Calls open interest is downshifting for Inovalon Holdings this week https://www.macroaxis.com/stock-options/INOV/Inovalon-Holdings?utm_source=dlvr.it&utm_medium=stocktwits
View on StockTwits ↗$INOV - Puts open interest is shifting for Inovalon Holdings this week https://www.macroaxis.com/stock-options/INOV/Inovalon-Holdings?utm_source=dlvr.it&utm_medium=stocktwits
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.